Literature DB >> 21570885

Pharmacokinetic monitoring of antiepileptic drugs.

A Aldaz1, R Ferriols, D Aumente, M V Calvo, M R Farre, B García, R Marqués, P Mas, B Porta, M Outeda, D Soy.   

Abstract

Monitoring plasma levels of antiepileptic drugs for the treatment and prophylaxis of epilepsy is one of the strategies enabling clinical results to improve by reducing adverse affects and increasing effectiveness. The objective of this article is to review the basic aspects in the monitoring of antiepileptic drugs using a consensus document prepared and endorsed by the pharmacokinetics and pharmacogenetics working group (PK.gen) of the Sociedad Española de Farmacia Hospitalaria (Spanish Society of Hospital Pharmacists).
Copyright © 2010 SEFH. Published by Elsevier Espana. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21570885     DOI: 10.1016/j.farma.2010.10.005

Source DB:  PubMed          Journal:  Farm Hosp        ISSN: 1130-6343


  4 in total

1.  Clinical pharmacokinetics: perceptions of hospital pharmacists in Qatar about how it was taught and how it is applied.

Authors:  Nadir Kheir; Ahmed Awaisu; Hoda Gad; Shereen Elazzazy; Farah Jibril; Mawadda Gajam
Journal:  Int J Clin Pharm       Date:  2015-09-04

2.  Therapeutic drug monitoring of levetiracetam in daily clinical practice: high-performance liquid chromatography versus immunoassay.

Authors:  Maria Mendoza Aguilera; María Dolores Bellés Medall; Tamara Álvarez Martín; Óscar Pascual Marmaneu; Carla Liñana Granell; Raúl Ferrando Piqueres
Journal:  Eur J Hosp Pharm       Date:  2018-10-20

3.  The relationship between pharmacokinetic parameters of carbamazepine and therapeutic response in epileptic patients.

Authors:  Chahra Chbili; Anis Hassine; Aicha Laouani; Sana Ben Amor; Manel Nouira; Sofiène Ben Ammou; Saad Saguem
Journal:  Arch Med Sci       Date:  2016-05-20       Impact factor: 3.318

4.  Exposure to valproic acid is associated with less pulmonary infiltrates and improvements in diverse clinical outcomes and laboratory parameters in patients hospitalized with COVID-19.

Authors:  Julio Collazos; Pere Domingo; Nerio Fernández-Araujo; Elia Asensi-Díaz; Helem Vilchez-Rueda; Antonio Lalueza; Emilia Roy-Vallejo; Rosa Blanes; Manuel Raya-Cruz; Jaime Sanz-Cánovas; Arturo Artero; José-Manuel Ramos-Rincón; Carlos Dueñas-Gutiérrez; José Luis Lamas-Ferreiro; Víctor Asensi
Journal:  PLoS One       Date:  2022-01-27       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.